These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 2600732)

  • 1. Preclinical development and characterization of an intravenous dosage form for the ACE inhibitor RS-10029.
    Visor GC; Lin LH; Henry P; Singer L
    J Parenter Sci Technol; 1989; 43(6):271-6. PubMed ID: 2600732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of a lyophilized dosage form of IL-1 beta.
    Visor GC; Tsai KP; Miller MD; Duffy J; Calderwood T; Lokensgard D; Killian J; Malefyt T; Gu L; Massey I
    Lymphokine Res; 1990; 9(3):425-34. PubMed ID: 2398744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE inhibitors for hypertension.
    Black P; Wrapson C
    N Z Med J; 2001 Jan; 114(1124):20-1. PubMed ID: 11243672
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceutical development, quality control, stability and compatibility of a parenteral lyophilized formulation of the investigational polymer-conjugated platinum antineoplastic agent AP5346.
    Van der Schoot SC; Nuijen B; Sood P; Thurmond KB; Stewart DR; Rice JR; Beijnen JH
    Pharmazie; 2006 Oct; 61(10):835-44. PubMed ID: 17069422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical and chemical stability of pemetrexed in infusion solutions.
    Zhang Y; Trissel LA
    Ann Pharmacother; 2006 Jun; 40(6):1082-5. PubMed ID: 16720706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of angiotensin converting enzyme (ACE) in plasma and tissues: studies ex vivo after administration of ACE inhibitors.
    Johnston CI; Mendelsohn FA; Cubela RB; Jackson B; Kohzuki M; Fabris B
    J Hypertens Suppl; 1988 Dec; 6(3):S17-22. PubMed ID: 2852234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility study of 5-fluorouracil with PVC bags after repackaging into two types of infusion admixtures.
    Benaji B; Faouzi MA; Dine T; Goudaliez F; Luyckx M; Brunet C; Kablan J; Gressier B; Cazin M; Cazin JC
    Therapie; 1999; 54(5):659-63. PubMed ID: 10667105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The improved dissolution and prevention of ampoule breakage attained by the introduction of pretreatment into the production process of the lyophilized formulation of recombinant human Interleukin-11 (rhIL-11).
    Hirakura Y; Kojima S; Okada A; Yokohama S; Yokota S
    Int J Pharm; 2004 Nov; 286(1-2):53-67. PubMed ID: 15501002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of drug physical form during granulation, tabletting and storage.
    Williams AC; Cooper VB; Thomas L; Griffith LJ; Petts CR; Booth SW
    Int J Pharm; 2004 May; 275(1-2):29-39. PubMed ID: 15081136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage.
    Passot S; Fonseca F; Alarcon-Lorca M; Rolland D; Marin M
    Eur J Pharm Biopharm; 2005 Aug; 60(3):335-48. PubMed ID: 15894475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation.
    Zhang JA; Anyarambhatla G; Ma L; Ugwu S; Xuan T; Sardone T; Ahmad I
    Eur J Pharm Biopharm; 2005 Jan; 59(1):177-87. PubMed ID: 15567316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of a freeze-dried recombinant streptokinase formulation without serum albumin.
    López M; González LR; Reyes N; Sotolongo J; Pujol V
    J Clin Pharm Ther; 2004 Aug; 29(4):367-73. PubMed ID: 15271104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compatibility of imipenem-cilastatin sodium with commonly used intravenous solutions.
    Bigley FP; Forsyth RJ; Henley MW
    Am J Hosp Pharm; 1986 Nov; 43(11):2803-9. PubMed ID: 3467590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current perspectives on stability of protein drug products during formulation, fill and finish operations.
    Rathore N; Rajan RS
    Biotechnol Prog; 2008; 24(3):504-14. PubMed ID: 18484778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro stability of two formulations of recombinant activated factor VIIa reconstituted in inappropriate solvents or at inappropriate volumes.
    Petersson B; Schönwandt AB; Thornstfeldt P; Nedergaard H; Jensen MB; Thornstergaard PB; Norsell T; Bjerre J
    Clin Ther; 2008 May; 30(5):917-23. PubMed ID: 18555938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical and chemical stability of palonosetron HCl in 4 infusion solutions.
    Trissel LA; Xu QA
    Ann Pharmacother; 2004 Oct; 38(10):1608-11. PubMed ID: 15328393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoscintigraphic assessment of the regional drug absorption of the dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, M100240, in healthy volunteers.
    Martin NE; Collison KR; Martin LL; Tardif S; Wilding I; Wray H; Barrett JS
    J Clin Pharmacol; 2003 May; 43(5):529-38. PubMed ID: 12751274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of polymorphic forms of ranitidine hydrochloride.
    Wu V; Rades T; Saville DJ
    Pharmazie; 2000 Jul; 55(7):508-12. PubMed ID: 10944778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Product development of AG-331 lyophilized powder for injection.
    Chiang CC; Fessler D; Freebern K; Thirucote R; Tyle P
    J Pharm Sci Technol; 1994; 48(1):24-9. PubMed ID: 8004414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.